CORRESP Filing
Rani Therapeutics Holdings, Inc.
Date: July 9, 2025 · CIK: 0001856725 · Accession: 0001193125-25-157074
AI Filing Summary & Sentiment
File numbers found in text: 333-288509
Show Raw Text
CORRESP 1 filename1.htm CORRESP July 9, 2025 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 RE: Rani Therapeutics Holdings, Inc. Registration Statement on Form S-3 File No. 333-288509 Ladies and Gentlemen: Rani Therapeutics Holdings, Inc. (the “ Registrant ”) hereby requests that the U.S. Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on July 11, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes John T. McKenna of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with John T. McKenna of Cooley LLP, counsel to the Registrant, at (650) 843-5059. Very truly yours, RANI THERAPEUTICS HOLDINGS, INC. By: /s/ S VAI S ANFORD Name: Svai Sanford Title: Chief Financial Officer cc: John T. McKenna, Cooley LLP